Abstract
Natural killer (NK) cells are key effectors of the innate immune system, protecting the host from a variety of infections, as well as malignant cells. Recent advances in the field of NK cell biology have led to a better understanding of how NK cells develop. This progress has directly translated to improved outcomes in patients receiving hematopoietic stem cell transplants to treat potentially lethal malignancies. However, key differences between mouse and human NK cell development and biology limits the use of rodents to attain a more in depth understanding of NK cell development. Therefore, a readily accessible and genetically tractable cell source to study human NK cell development is warranted. Our lab has pioneered the development of lymphocytes, specifically NK cells, from human embryonic stem cells (hESCs) and more recently induced pluripotent stem cells (iPSCs). This chapter describes a reliable method to generate NK cells from hESCs and iPSCs using murine stromal cell lines. Additionally, we include an updated approach using a spin-embryoid body (spin-EB) differentiation system that allows for human NK cell development completely defined in vitro conditions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Woll PS, Martin CH, Miller JS, Kaufman DS (2005) Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity. J Immunol 175:5095–5103
Woll PS, Grzywacz B, Tian X et al (2009) Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity. Blood 113:6094–6101
Ni Z, Knorr DA, Clouser CL et al (2011) Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity utilizing diverse cellular mechanisms. J Virol 85(1):43–50
Wilber A, Linehan JL, Tian X et al (2007) Efficient and stable transgene expression in human embryonic stem cells using transposon-Âmediated gene transfer (Dayton, Ohio). Stem Cells 25:2919–2927
Giudice A, Trounson A (2008) Genetic modification of human embryonic stem cells for derivation of target cells. Cell Stem Cell 2:422–433
Ng ES, Davis R, Stanley EG, Elefanty AG (2008) A protocol describing the use of a recombinant protein-based, animal product-Âfree medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies. Nat Protoc 3:768–776
Ng ES, Davis RP, Azzola L, Stanley EG, Elefanty AG (2005) Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood 106:1601–1603
Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA (2001) Hematopoietic colony-Âforming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 98:10716–10721
Ledran MH, Krassowska A, Armstrong L et al (2008) Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell 3:85–98
Tian X, Morris JK, Linehan JL, Kaufman DS (2004) Cytokine requirements differ for stroma and embryoid body-mediated hematopoiesis from human embryonic stem cells. Exp Hematol 32:1000–1009
Ng ES, Davis RP, Hatzistavrou T, Stanley EG, Elefanty AG (2008) Directed differentiation of human embryonic stem cells as spin embryoid bodies and a description of the hematopoietic blast colony forming assay. Curr Protoc Stem Cell Biol; Chapter 1:Unit 1D 3
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Ni, Z., Knorr, D.A., Kaufman, D.S. (2013). Hematopoietic and Nature Killer Cell Development from Human Pluripotent Stem Cells. In: Zavazava, N. (eds) Embryonic Stem Cell Immunobiology. Methods in Molecular Biology, vol 1029. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-478-4_3
Download citation
DOI: https://doi.org/10.1007/978-1-62703-478-4_3
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-477-7
Online ISBN: 978-1-62703-478-4
eBook Packages: Springer Protocols